Evidence map›Paper›PMID 35185879›Full record

ReviewFrontiers in immunology2022

Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy.

Ting Zhao, Qi Yang, Yujiang Xi, Zhaohu Xie, Jiayan Shen, Zhenmin Li, Zhaofu Li, Dongdong Qin

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. [Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  18. Review
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ting ZhaoSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Qi YangSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Yujiang XiSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Zhaohu XieSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Jiayan ShenSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Zhenmin LiSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Zhaofu LiSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Dongdong QinSchool of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, China.
Yunnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is one of the newly discovered forms of cell-regulated death characterized by iron-dependent lipid peroxidation. Extensive research has focused on the roles of ferroptosis in tumors, blood diseases, and neurological diseases. Some recent findings have indicated that ferroptosis may also be related to the occurrence and development of inflammatory arthritis. Ferroptosis may be a potential therapeutic target, and few studies

Indexed as

AnimalsArthritis, RheumatoidFerroptosisHumansInflammationIronLipid PeroxidationReactive Oxygen SpeciesIronReactive Oxygen Speciesferroptosislipid peroxidationreactive oxygen speciesrheumatoid arthritistherapeutic strategy

Identifiers

PMID35185879
PMCPMC8847160
OpenAlexW4210432818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.